95 results found.
        
Revenue Review: 1H18 Growth and 2Q18 Performance Highlights for Public Companies
by Julie A. Vetalice The 21 companies tracked below collectively grew +3.6% in 1H18 vs. 1H17, still on track to reach our estimates of +3.7% in orthopaedic industry growth for 2018 vs. 2017. Exhibits 1 and 2 reflect 1H18 results for public orthopaedic companies. The performan...
Smith & Nephew Posts 2Q18 Ortho Revenue Growth +4% YoY
ORTHOWORLD estimates Smith & Nephew 2Q18 orthopaedic revenue of US $870.8MM, +4.4% from 2Q17, and 1H18 revenue of $1,7...
Public Orthopaedic Companies: 1Q18 Revenue and Growth Drivers
By Julie A. Vetalice The 21 companies tracked in Exhibits 1 and 2 collectively grew +3.1% in 1Q18 vs. 1Q17, remaining on track alongside our estimates of +3.7% in orthopaedic industry growth for 2018 vs. 2017. (Review
Smith & Nephew Posts 6% Growth in Knees for 1Q18
ORTHOWORLD estimates Smith & Nephew 1Q18 orthopaedic revenue of US $865.4MM, +4.7% from 1Q17.
ConforMIS Posts 1Q18 Revenue
ConforMIS announced 1Q18 revenue of US $19.7MM, -3.9% vs. 1Q17.
Anika Therapeutics Reports 1Q18 Orthobiologic Revenue
Anika Therapeutics posted 1Q18 orthobiologic revenue of US $19.5MM, -3.6% vs. 1Q17.
Smith & Nephew Appoints Namal Nawana as CEO
Smith & Nephew has appointed Mr. Namal Nawana as Chief Executive Officer and successor to Mr. Olivier Bohuon, effective May 2018.
Public Orthopaedic Companies: 2017 Revenue and 2018 Sales Drivers
By Julie A. Vetalice The 20 companies tracked in Exhibits 1 and 2 collectively grew +3.0% in 2017 vs. 2016. Individually, you’ll notice some stellar performance in particular segments. (Our final estimates for 2017 orthopaedic industry revenue can be found in
Smith & Nephew Posts 4Q17/2017 Revenue, Unveils Cost-Cutting Plan
ORTHOWORLD estimates Smith & Nephew 4Q17 orthopaedic revenue of US $899.3MM, +5.2% from 4Q16, and 2017 revenue of ...
OrthoPediatrics Posts 3Q17 YoY Growth of 22%
OrthoPediatrics posted 3Q17 revenue of US $12.4MM, +22.1% vs. 3Q16, and YTD revenue of $34.0MM, +22.2%
Majority of Public Orthopaedic Companies Still on Track for Full-Year Guidance
By Julie A. Vetalice Looking at 3Q17 revenue and reading call transcripts, much was said about unforeseen headwinds that crept in before the close of the year, affecting orthopaedic companies in a variety of ways. Following weather events, oft-cited “softness&rdqu...
Smith & Nephew 3Q17 Orthopaedic Revenue +3% YoY
ORTHOWORLD estimates Smith & Nephew 3Q17 orthopaedic revenue of US $793.2MM, +3.3% from 3Q16, and YTD revenue of
Smith & Nephew CEO Announces Retirement; Acquisition Buzz Returns
Smith & Nephew's Chief Executive Officer, Olivier Bohuon, announced his intention to retire by the end of 2018 after seven years in the positio...
Sales Results for 20 Orthopaedic Companies: A Mid-year Status Report
By Julie A. Vetalice Now that we’ve collected 1H17 results from 20 publicly-traded companies, I’d like to share some performance-based observations. With now just 4 months remaining in the year, these companies provide a helpful gauge in projecting industry growth.
Smith & Nephew 2Q17 Orthopaedic Revenue
ORTHOWORLD estimates Smith & Nephew 2Q17 orthopaedic revenue of US $834.0MM, +1.1% from 2Q16, and 1H17 revenue of $1,660.9MM, +2.0%
Anika Therapeutics Posts Orthobiologics Sales Growth for 2Q17/1H17
Anika Therapeutics posted 2Q17 orthobiologic revenue of US $24.5MM, +5.0% vs. 2Q16, and 1H17 revenue of
DePuy Synthes Company Profile
We're redesigning Company Profiles. To get the most current news and articles about DePuy Synthes in the interim,
David Dvorak Departs as Zimmer Biomet CEO
Zimmer Biomet announced the departure of David Dvorak, its CEO of ten years. Dan Florin, Senior Vice President and CFO,...
Public and Private Company Revenue Review: 1Q17
By Julie A. Vetalice We're eager to see 2Q17 results to prepare a 1H review for you. In the interim, here are the 1Q17 numbers for publicly-traded companies, with updates and estimates for a number of privately-traded companies, too. Exhibits 1 and 2 illustrate 1Q17 performanc...
Wright Medical's 1Q17 Revenue
Wright Medical reported 1Q17 revenue of US $177.2MM, +4.7% from 1Q16. (U.S. $132.1MM, +6.1%; ex-U.S. $45.0MM, +0.6%
Smith & Nephew Reports 1Q17 Revenue
ORTHOWORLD estimates Smith & Nephew 1Q17 orthopaedic revenue of US $826.9MM, +3.0% from 1Q16.
Smith & Nephew Company Profile
We're redesigning Company Profiles. To get the most current news and articles about Smith & Nephew in the interim,
Company Revenue 2016
For these publicly-traded orthopaedic device companies, Exhibits 1 and 2 present 2016 orthopaedic revenue and growth. Exhibit 1 includes links to company's full-year revenue reporting, as well. ...
Top 5 Orthopaedic Players Post Revenue Growth
Combined, the top five largest players in orthopaedics posted 2016 revenue of US $28.6BB, up $671.7MM or +2.4% vs. ...
Smith & Nephew 2016 Revenue
ORTHOWORLD estimates Smith & Nephew 2016 orthopaedic revenue of US $3,250.5MM, +2.8% from 2015, with 4Q16 revenue of $854.9MM, -1.3% vs. 4Q15.
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group